Interestingly, the frequency of BRCA1 germline mutations in Chinese is significantly higher than that in Western ovarian cancer patients, which also supported the different mutational patterns of ovarian cancer patients in different regions. This evidence concerns the gene BRCA1 and ovarian carcinoma.